The broad-spectrum caspase inhibitor zVAD abrogated apoptosis in cancer cells co-treated with PAM and TRAIL (Table 1 and Table 2, Supplementary Figure S2a,b), confirming that PAM/TRAIL treatment induces apoptosis in various TRAIL-resistant cancer cells but not in normal cells. Here, TNFSF10 is linked to cancer.